About Amgen Rockville (NASDAQ:MITI)
Designs and develops antibody-based drugs for treatment of cancer. The Company is a biotechnology company with a focus on the development of antibody-based products for cancer and inflammatory and autoimmune diseases. Micromet has established a drug development platform based on its BiTE technology, a drug format that leverages the cytotoxic potential of T cells.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Amgen Rockville (NASDAQ:MITI) Frequently Asked Questions
What is Amgen Rockville's stock symbol?
Amgen Rockville trades on the NASDAQ under the ticker symbol "MITI."
Who are some of Amgen Rockville's key competitors?
Some companies that are related to Amgen Rockville include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), GlaxoSmithKline (GSK), Thermo Fisher Scientific (TMO), AstraZeneca (AZN), Sanofi (SAN), Bayer (BAYN), Celgene (CELG) and CSL (CSL).
How do I buy Amgen Rockville stock?
Shares of Amgen Rockville can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Amgen Rockville?
Amgen Rockville's mailing address is 9201 Corporate Blvd Ste 400, ROCKVILLE, MD 20850-7209, United States. The biotechnology company can be reached via phone at +1-240-7521420.
MarketBeat Community Rating for Amgen Rockville (MITI)MarketBeat's community ratings are surveys of what our community members think about Amgen Rockville and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Amgen Rockville (NASDAQ:MITI) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Amgen Rockville (NASDAQ:MITI) Earnings History and Estimates Chart
Amgen Rockville (NASDAQ MITI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Amgen Rockville (NASDAQ:MITI) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Amgen Rockville (NASDAQ:MITI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Amgen Rockville (NASDAQ MITI)
No insider trades for this company have been tracked by MarketBeat.com
Amgen Rockville (NASDAQ MITI) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Amgen Rockville (NASDAQ:MITI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Amgen Rockville (NASDAQ:MITI) Income Statement, Balance Sheet and Cash Flow Statement
Amgen Rockville (NASDAQ MITI) Stock Chart for Saturday, February, 24, 2018